DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74
Last updated 2013-04-02
Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This laboratory study is looking at DNA in tissue samples from patients with head and neck cancer.
Conditions
Interventions
- GENETIC
-
cytogenetic analysis
- GENETIC
-
gene expression analysis
- GENETIC
-
mutation analysis
- GENETIC
-
polymerase chain reaction
- OTHER
-
immunohistochemistry staining method
- OTHER
-
laboratory biomarker analysis
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Vanderbilt-Ingram Cancer Center
lead OTHER
Principal Investigators
-
Barbara Murphy, MD · Vanderbilt-Ingram Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
More Related Trials
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Study of Proteins in Head and Neck Cancer Cells
NCT00896948 ·Status: COMPLETED
-
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
NCT00482872 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
NCT00898430 ·Status: TERMINATED
-
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171 ·Status: COMPLETED
-
Liquid Biopsy in Head and Neck Cancer
NCT03926468 ·Status: UNKNOWN
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00898742 ·Status: TERMINATED
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Study of Hair Samples From Patients With Cancer
NCT00899691 ·Status: COMPLETED
-
Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
NCT00896675 ·Status: COMPLETED
-
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438 ·Status: COMPLETED
-
Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
NCT00898300 ·Status: COMPLETED
-
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
NCT01487733 ·Status: COMPLETED
-
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
NCT00904514 ·Status: TERMINATED
-
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT04099290 ·Status: RECRUITING
-
Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
NCT00899704 ·Status: WITHDRAWN
-
Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00898911 ·Status: COMPLETED
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
NCT00897117 ·Status: RECRUITING
-
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
NCT00580203 ·Status: COMPLETED
-
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
NCT06420219 ·Status: RECRUITING
-
MicroRNA Markers in Head and Neck Cancers
NCT04305366 ·Status: ACTIVE_NOT_RECRUITING
-
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
NCT02245100 ·Status: COMPLETED
-
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
NCT06094985 ·Status: RECRUITING